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(37.74 vs. 36.01, p = 0.031). Patients with CoA and type 
1A BAV had significantly less valve regurgitation (13.6 vs. 
55.8 %, p < 0.001) and smaller diameters of the ascending 
aorta (33.7 vs. 37.8 mm, p < 0.001) and aortic arch (25.8 vs. 
30.2 mm, p < 0.001) than patients with isolated BAV.
Conclusions Type 1A BAV with complete raphe is asso-
ciated with more aortic regurgitation and root dilatation. 
The majority of CoA patients have incomplete raphes, as-
sociated with smaller aortic root diameters and less valve 
regurgitation.
Keywords Aortic diseases · Echocardiography · Heart 
defects, Congenital · Valvular heart disease
Introduction
Bicuspid aortic valve (BAV) is the most common congenital 
cardiac malformation, with a clear male predominance and 
an estimated prevalence of 0.5− 2 % [1–3]. BAV can occur 
in an isolated form or in association with other congenital 
malformations, such as coarctation of the aorta (CoA). The 
prevalence of BAV in CoA patients is reported to be as high 
as 60 % [4, 5].
Although some patients with isolated BAV remain asymp-
tomatic throughout their lifetime, others develop severe 
cardiac complications from an early age onwards, such as 
aortic valve stenosis, aortic insufficiency and/or endocardi-
tis. However, the first presentation can also be a clinically 
relevant aortic wall abnormality, including ascending aor-
tic dilatation (reported to occur in 45 % of patients [6]) or 
rupture of the ascending aorta. Identifying patients who are 
prone to develop complications is a major challenge [7].
It is now recognised that BAV should not be considered 
to be one single entity, but that distinct morphological phe-
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Background The clinical course of bicuspid aortic valves 
(BAVs) is variable. Data on predictors of aortopathy and 
valvular dysfunction mainly focus on valve morphology.
Aim To determine whether the presence and extent of the 
raphe (fusion site of valve leaflets) is associated with the 
degree of aortopathy and valvular dysfunction in patients 
with isolated BAV and associated aortic coarctation (CoA).
Methods Valve morphology and aortic dimensions of 
255 BAV patients were evaluated retrospectively by 
echocardiography.
Results BAVs with a complete raphe had a significantly 
higher prevalence of valve dysfunction (especially aortic 
regurgitation) than BAVs with incomplete raphes (82.9 
vs. 66.7 %, p = 0.01). Type 1A BAVs (fusion of right and 
left coronary leaflets) and complete raphe had larger aortic 
sinus diameters compared with the rest of the population 
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notypes are distinguishable based on the presence and num-
ber of raphes, as classified by Sievers et al. [8]. Most BAVs 
consist of one free leaflet and two leaflets that are conjoined 
(or have failed to separate during embryonic development). 
The term ‘raphe’ defines the conjoined area of the two 
underdeveloped leaflets turning into a malformed commis-
sure between both leaflets [8]. When no raphe is present, 
the valve is called strictly bicuspid. Schaefer et al. identified 
three BAV morphologies: type 1 with fusion of the right and 
left coronary cusp; type 2 with right and non-coronary cusp 
fusion; and the rare type 3 with left and non-coronary cusp 
fusion [9]. In this study, this classification was followed, 
with addition of A (for valves with a raphe) or B (for strictly 
bicuspid valves, Fig. 1).
Several studies have shown before that different BAV 
phenotypes have a different clinical outcome, regarding 
valvular dysfunction and aortopathy [9–14]. To our knowl-
edge, however, the extent of the raphe (i.e. the extent to 
which the leaflets are conjoined) has never been taken into 
account. Therefore, the purpose of this study was to deter-
mine whether the extent of the raphe is associated with the 
degree of aortopathy and valvular dysfunction.
As stated before, the most common associated congeni-
tal malformation of BAV is coarctation of the aorta (CoA). 
Whereas in isolated BAV the most common morphology is a 
fusion of the right and left coronary cusp (type 1A in 80 % of 
patients [9]), data on the distribution of BAV morphology in 
CoA patients are limited [15]. Therefore, a sub-analysis was 
performed in patients with BAV and CoA to see if there was 
a difference in BAV morphology and extent of the raphe.
Methods
Study population
All patients who had undergone transthoracic echocar-
diography (TTE) between 2005 and 2010 and had been 
diagnosed with BAV disease were identified from the echo-
cardiography database. A total of 263 BAV patients were 
selected, in 8 patients the diagnosis of BAV was not correct 
Fig. 1 Schematic overview of bicuspid aortic valve (BAV) morpholo-
gies. The drawings are oriented in an echocardiographic view of the 
aortic valve. Upper panel: The three major valve morphologies ob-
served in BAV patients are described as three different types based on 
the valve leaflet orientation: type 1,2 and 3. The extent of the raphe is 
indicated as analysed in this study (incomplete or complete). Lower 
panel: Strictly bicuspid valves (without a raphe) are defined as a sub-
group B. Modified after Schaefer et al. [9]
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(EPD-Vision®, LUMC) and the echocardiography database, 
respectively. For this analysis of clinically acquired data, the 
Institutional Review Board waived the need for patient writ-
ten informed consent.
Classification of valve morphology
As from a developmental point of view a morphological 
spectrum may exist in which the extent of the raphe can be 
regarded as a continuum, in the current study we chose to 
describe the major valve morphologies observed in BAV 
patients as 3 different types (type 1A, 2A and 3A, based on 
valve leaflet orientation, modified after Schaefer et al. [9]), 
in which the extent of the raphe can vary (Fig. 1). We defined 
fusion of the right and left coronary cusp as type 1A BAV, 
fusion of the right and non-coronary cusp as type 2A BAV 
and fusion of the left and non-coronary cusp as type 3A BAV. 
Strictly bicuspid valves (i.e. a valves without a raphe) were 
defined as being either type 1, 2 or 3, based on the orienta-
tion of their leaflets, and referred as a subgroup B (Fig. 1).
Echocardiography
Transthoracic echocardiography was performed using a GE 
Vivid7 or E9 (GE-Vingmed, Horten, Norway) ultrasound 
machine with standard views from the parasternal, subcos-
tal, suprasternal and apical windows. The aortic valve was 
examined in the two-dimensional parasternal short-axis 
view and classified as bicuspid when two cusps could be 
clearly identified and the typical ‘fish-mouth opening’ of the 
valve was observed (Fig. 2). Diameters of the aortic root 
and ascending aorta were determined in the parasternal 
long-axis view.
Echocardiographic analysis
All echocardiograms were evaluated by an experienced 
observer, using GE Medical System’s EchoPac, Version 7 
(110.0.0, GE-Vingmed, Horten, Norway). The aortic valve 
was evaluated in a cross-sectional view for the presence and 
extent of a raphe. For valves where a raphe could be dis-
tinguished (subgroup A), distinction was made between a 
complete raphe and an incomplete raphe. Cases where no 
[16], thus 255 patients remained. Clinical and echocardio-
graphic data were collected and analysed for these patients 
from the departmental Cardiology Information System 
Fig. 2 9  Representative examples of different bicuspid aortic valve 
(BAV) types as seen from the short-axis parasternal view on echo-
cardiography. The yellow arrow indicates the raphe. The orange star 
indicates the typical fish mouth opening of the valve. a Type 1A in 
open position. b Type 1A with complete raphe in closed position. c 
Type 1A with incomplete raphe in closed position. d Type 1B in open 
position. e Type 1B in closed position. f Type 2A in open position. g 
Type 2A with complete raphe in closed position. h Type 2A with in-
complete raphe in closed position. i Type 2B in open position. j Type 
2B in closed position
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(Table 1). Mean age was not significantly different in the dif-
ferent BAV subgroups (p = 0.515, Table 2) or in patients with 
incomplete and complete raphes (p = 0.357). There were no 
significant differences in valvular function between the dif-
ferent morphological subtypes. However, BAVs with a com-
plete raphe had a significantly higher prevalence of valvular 
raphe was detected (subgroup B) were defined as strictly 
bicuspid valves. Diameters of aortic sinus, ascending aorta 
and aortic arch were measured from leading edge to leading 
edge in end-diastole according to the European Association 
of Echocardiography recommendations [17]. Aortic annu-
lar diameter was measured from inner edge to inner edge 
during systole. All measurements were in mm, rounded to 
2 significant figures. The ascending aorta was considered 
dilated at a diameter of > 38 mm.
Valvular dysfunction was defined as aortic stenosis or 
regurgitation. European Association of Echocardiography 
(EAE) recommendations were used for determining sever-
ity of aortic stenosis and regurgitation, grading from mild 
to severe [18, 19]. Subgroup analysis was performed in 
patients with a history of CoA, the same protocol was fol-
lowed in this group.
Statistical analysis
All collected data were registered in a Microsoft Office 
Access 2003 database. The database was exported into IBM 
SPSS Statistics Version 20 for computing variables and sta-
tistical analysis. Independent samples T-tests were used to 
compare means of numerical data in two categories. One-
way ANOVA tests were used for comparing numerical data 
in more than two categories. Cross-tabulations were made 
for binary categorical data, on which chi-square goodness-
of-fit-tests were performed to test for independence. For 
sets of independent numerical data linear regression analy-
sis was used to evaluate trends. Similarly, trends for binary 
categories were evaluated with binary logistic regression 
to correct for possible confounding factors such as age and 
gender. All statistical analyses were two-tailed and consid-
ered significant if p < 0.05.
Results
Patient characteristics
A total of 255 patients with BAV (age 18–85 years, mean 
48 ± 15 years) were identified and analysed [16]. Of these, 
179 were male (70.2 %) and 76 female (29.8 %). Patient 
characteristics and echocardiographic data are summarised 
in Table 1. Baseline characteristics were not significantly 
different between the BAV subtypes (Table 2). The distribu-
tion of valve morphology is shown in Fig. 3.
More valvular dysfunction in BAVs with complete raphe
A total of 120 patients were diagnosed with aortic stenosis, 
the same number of patients showed aortic regurgitation 





Bicuspid aortic valve morphology
Type 1A 151 (59.2)
Type 2A 37 (14.5)
Type 3A 1 (0.4)
Strictly bicuspid (type B) Type 1B Type 
2B
66 (25.9) 42 (63.6) 24 
(36.4)
Extent of the raphe
Complete 111 (43.5)
Incomplete 78 (30.6)
Valve surgery 66 (25.9)
Mitral valve replacement 1 (0.39)
Mitral valve repair 2 (0.78)
Aortic valve replacement 50 (19.6)
Aortic valve repair 10 (3.9)
Bentall 22 (8.6)
Tricuspid valve repair 1 (0.39)
Pulmonary valve replacement 1 (0.39)
Congenital defects 51 (20.0)
Aortic coarctation 39 (15.3)
Atrial septal defect 1 (0.39)
Ventricular septal defect 11 (4.3)
Marfan 2 (0.78)
Common truncus 1 (0.39)
Patent ductus arteriosus 5 (2.0)
Valvular dysfunction 189 (74.1)
Aortic valve stenosis 120 (47.1)
Aortic valve regurgitation 120 (47.1)
Mitral valve regurgitation 16 (6.3)
Tricuspid valve regurgitation 8 (3.1)
Pulmonary valve stenosis 1 (0.39)
Pulmonary valve regurgitation 1 (0.39)
Medication 140 (54.9)
ACE inhibitors 91 (35.7)
Statins 61 (23.9)
Carbasalate calcium 45 (17.6)
Oral anticoagulants 43 (16.9)
Antiarrhythmic drugs 33 (12.9)




Cerebrovascular accident 14 (5.5)
Hypercholesterolaemia 33 (12.9)
Peripheral arterial disease 7 (2.7)
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ference in sinus diameter (37.74 vs. 36.01, p = 0.031) com-
pared with the rest of the study population.
More incomplete raphes in CoA patients
Patients with CoA constituted the largest group of patients 
with associated congenital cardiac malformations (n = 39). 
Patients with a history of CoA were 9 years younger than 
those without (40.7 vs. 49.3 years old, p < 0.001) and there 
was no statistical difference in gender (p = 0.47).
Distribution of BAV morphology in patients with CoA 
was identical to the rest of the study population, the majority 
having a type 1A BAV (56.4 % in patients with vs. 59.7 % in 
patients without CoA, p = 0.321). However, in the majority 
(72.7 %) of CoA patients and type 1A BAV an incomplete 
raphe was seen as compared with only 38.8 % in the popula-
tion without CoA (Table 6).
Patients with CoA and type 1A BAV had significantly 
less valve regurgitation (13.6 vs. 55.8 %, p < 0.001) and 
significantly smaller diameters of the ascending aorta (33.7 
vs. 37.8 mm, p < 0.001) and aortic arch (25.8 vs. 30.2 mm, 
p < 0.001) than type 1A patients with isolated BAV (Table 6).
dysfunction than BAVs with an incomplete raphe (82.9 vs. 
66.7 %, p = 0.01, Table 3). When specifying this for type of 
valvular dysfunction, this difference remained significant in 
patients with aortic regurgitation (56.8 vs. 42.3 %, p = 0.05), 
whereas in patients with aortic stenosis there was no differ-
ence between patients with a complete or incomplete raphe 
(49.5 vs. 43.6 %, p = 0.419, Table 3). In type 1A BAVs with a 
complete raphe the difference in prevalence of aortic regur-
gitation was even more outspoken compared with the rest of 
the study population (57.6 vs. 41.8 % p = 0.017).
Larger aortic diameter in type 1A BAVs and complete 
raphe
All type 1A BAVs, compared with type 2A BAVs, showed 
a significantly larger sinus (37.29 vs. 33.89 mm, p = 0.001, 
Table 4). Valves with a complete raphe had significantly 
larger aortic diameters at the level of the ascending aorta, as 
compared with valves with an incomplete raphe (38.02 vs. 
35.01, p = 0.041). At the level of the aortic sinus and aortic 
arch this difference was not significant (Table 5). Type 1A 
BAVs and a complete raphe also showed a significant dif-
Neth Heart J (2016) 24:127–133
Table 2 Patient characteristics of different BAV subgroups
Total n = 255 Type 1A n = 151 Type 2A n = 37 Type 3A n = 1 Type B n = 66 p-value
Gender (male) 179 (70 %) 110 (73 %) 23 (62 %) 0 (0 %) 46 (70 %) 0.260
Age (years) 48 ± 15 49 ± 14 46 ± 17 42 ± 25 47 ± 15 0.515
Risk factors
Diabetes 11 (4 %) 8 (5 %) 2 (5 %) 0 (0 %) 1 (2 %) 0.609
Hypertension 65 (26 %) 44 (29 %) 8 (22 %) 0 (0 %) 13 (20 %) 0.414
Hypercholesterolaemia 33 (13 %) 23 (15 %) 3 (8 %) 0 (0 %) 7 (11 %) 0.585
Smoking 51 (20 %) 31 (21 %) 8 (22 %) 0 (0 %) 12 (18 %) 0.925
Medication
Carbasalate calcium 45 (18 %) 19 (13 %) 8 (22 %) 1 (100 %) 17 (26 %) 0.013
Statins 59 (23 %) 31 (21 %) 9 (24 %) 1 (100 %) 18 (27 %) 0.207
ACE inhibitor 89 (35 %) 59 (39 %) 12 (32 %) 0 (0 %) 18 (28 %) 0.352
Oral anticoagulants 42 (17 %) 28 (19 %) 6 (16 %) 0 (0 %) 0 (0 %) 0.068
Fig. 3 Schematic overview of the distribution of valve morphologies 
in the study population
 Table 3 Valve morphology as related to dysfunction





Valve dysfunction (n = 144) 92 (82.9 %) 52 (66.7 %) 0.01
Aortic regurgitation (n = 96) 63 (56.8 %) 33 (42.3 %) 0.05
Aortic stenosis (n = 89) 55 (49.5 %) 34 (43.6 %) NS
Table 4 Valve morphology as related to aortic diameter; type 1A ver-
sus type 2A
Aortic diameter Type 1A Type 2A p value
Sinus (mm) 37.29 ± 5.88 33.89 ± 4.84 0.001
Ascendens (mm) 37.34 ± 6.75 36.33 ± 7.03 NS
Arch (mm) 29.30 ± 5.45 30.94 ± 4.70 NS
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significant difference in ascending aorta diameter between 
BAVs with a complete versus incomplete raphe. Differences 
in dilation might therefore be explained by the extent of the 
raphe, e.g. due to altered flow, although this remains specu-
lative at this point.
Patients with type 1A BAVs and a complete raphe 
showed significantly more regurgitation and root dilation as 
compared with the rest of the study population. Therefore, 
type 1A BAVs can be regarded as the valve orientation with 
the highest risk, which is in line with previous studies [11, 
22, 23]. This indicates that type 1A BAVs that also have a 
complete raphe should even be monitored more closely for 
valve regurgitation and aortopathy.
Effect of CoA on BAV morphology and outcome
Subgroup analysis of the CoA group revealed that these 
patients are on average 9 years younger than the rest of the 
study population, which may be explained by the fact that 
these patients usually show symptoms earlier and are often 
referred from the paediatric cardiologist as soon as they 
reach adulthood. The prevalence of BAV in CoA patients is 
an estimated 60 % [4, 5]. The majority of patients in the cur-
rent study had type 1A BAV, which corresponds to reports 
in the literature [15]. CoA patients had smaller aortic root 
diameters and less valve regurgitation, which might be 
explained by the fact that less CoA patients had a BAV with 
a complete raphe. Another explanation for the smaller aortic 
root diameters could be the younger age of CoA patients. 
The prevalence of stenosis was similar in the CoA group 
compared with the rest of the study population. This in con-
trast to earlier research which found an association between 
CoA and valve dysfunction [5], although in that study the 
extent of raphe was not taken into account.
Study limitations
This was a retrospective analysis of clinically obtained 
patient data derived from a single centre. A retrospective 
analysis is subjected to selection bias, as the investigator 
self-selects the cases. All patients were followed in a ter-
tiary referral centre, which may have led to a selection bias 
of more severely affected patients. Both biases were mini-
mised by including consecutive BAV patients who under-
went echocardiography between 2005 and 2010.
Conclusions and clinical implications
This study shows that the extent of the raphe is of clini-
cal importance, as a complete raphe predisposes to more 
valvular dysfunction and aortopathy. Moreover, patients 
Discussion
Key findings of this study are (1) Patients with type 1A BAV 
and a complete raphe show more aortic regurgitation and 
root dilatation as compared with the rest of the study pop-
ulation; (2) The majority of CoA patients have an incom-
plete raphe and smaller aortic root diameters and less valve 
regurgitation.
Extent of the raphe as predictor of outcome
An association has been described between aortic stenosis 
and type 2 BAVs [12, 20]; however, in those studies no dis-
tinction was made between the presence or not of a raphe. 
In the current study, the same trend was seen, but this find-
ing was not significant (p = 0.252). Also a relation has been 
shown between type 1A BAVs and aortic regurgitation [21], 
which is in line with the current study. The most impor-
tant findings of the current study, however, were related to 
the extent of the raphe. A complete raphe predisposed for 
larger aortic diameters and more valve regurgitation. To our 
knowledge, the extent of a raphe in BAV disease has not 
been studied previously as a prognostic factor. The worse 
outcome observed in patients with a complete raphe is pos-
sibly due to the fact that BAVs with incomplete raphes have 
a more physiological, tricuspid-like opening and therefore 
function better. BAVs with complete raphes seem to have 
more unevenly sized leaflets and smaller openings which 
may predispose to valve dysfunction.
Type 1A BAVs have been related to aortic sinus dilata-
tion -which is in line with the current study- and type 2A 
BAVs have been associated with dilatation of the ascending 
aorta [9, 11, 13]. However, none of these studies take into 
account the extent of the raphe. The current study showed a 
Table 5 Valve morphology as related to aortic diameter in all types 
BAV with complete raphe versus all types BAV with incomplete raphe
Aortic diameter Complete raphe Incomplete raphe p value
Sinus (mm) 36.91 ± 5.82 36.13 ± 5.81 NS
Ascendens (mm) 38.02 ± 6.53 35.91 ± 7.00 0.041
Arch (mm) 30.07 ± 5.16 29.21 ± 5.66 NS
Table 6 Characteristics of patients with type 1A bicuspid aortic valves 
(BAVs) with coarctation of the aorta (CoA) versus without CoA
Variable CoA No CoA p value
Type 1A BAV, n 
(%)
22 (56.4 %) 129 (59.7 %) NS
Raphe 0.003
 Incomplete, n (%) 16 (72.7 %) 50 (38.8 %)
 Complete, n (%) 6 (27.3 %) 79 (61.2 %)
Ascendens (mm) 33.3 ± 6.06 37.8 ± 6.78 < 0.001
Arch (mm) 25.5 ± 4.77 30.2 ± 4.98 < 0.001
Valve regurgitation 3 (13.6 %) 72 (55.8 %) < 0.001
Valve stenosis 10 (45.5 %) 56 (43.4 % NS
Neth Heart J (2016) 24:127–133
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with type 1A BAV and a complete raphe show more aor-
tic regurgitation and root dilatation as compared with the 
rest of the study population. This could indicate that this 
group of patients needs closer monitoring and more regular 
follow-up.
On the other hand, this study shows that patients with 
a bicuspid aortic valve and coarctation of the aorta have 
smaller aortic root diameters and less valve regurgitation, 
possibly due to the fact that in this group of patients the 
majority have an incomplete raphe.
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